Mereo BioPharma Group (MREO)
3.10
0.04 (1.31%)
At close: Jan 15, 2025, 12:09 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -51.7 | -13.23 | 66.37 | -7.39 | -8.41 | -14.44 | -11.56 | -10.25 | n/a |
| PS Ratio | 152.33 | 300.20 | 23.16 | 3.08K | -2.40K | n/a | -136.54 | n/a | n/a |
| PB Ratio | 30.14 | 7.31 | 9.60 | -80.76 | 7.28 | 14.11 | 7.18 | 3.67 | n/a |
| P/FCF Ratio | -70.69 | -11.65 | -146.26 | -42.64 | -6.38 | -19.96 | -13.02 | -10.62 | n/a |
| P/OCF Ratio | -72.09 | -11.65 | -161.2 | -42.66 | -6.38 | -19.99 | -13.95 | -10.63 | n/a |
| OCF/S Ratio | -2.11 | -25.76 | -0.14 | -72.11 | 376.48 | n/a | 9.79 | n/a | n/a |
| Debt / Equity Ratio | 0.12 | 0.21 | 0.19 | -1.2 | 0.81 | 0.66 | 0.33 | 0.04 | 0.03 |
| Quick Ratio | 6.72 | 2.63 | 8.06 | 4.01 | 1.42 | 2.15 | 6.83 | 35.74 | 28.85 |
| Current Ratio | 6.72 | 2.52 | 7.92 | 3.47 | 1.02 | 2.13 | 6.57 | 18.94 | 28.85 |
| Asset Turnover | 0.15 | 0.02 | 0.29 | 0.01 | -0.00 | n/a | -0.03 | n/a | n/a |
| Interest Coverage | -9.86 | -12.96 | -5.23 | -5.89 | -11.3 | -14.91 | -41.57 | -201.26 | n/a |
| Return on Equity (ROE) | -0.58 | -0.55 | 0.14 | 10.93 | -0.87 | -0.98 | -0.62 | -0.36 | n/a |
| Return on Assets (ROA) | -0.44 | -0.39 | 0.10 | -2.6 | -0.4 | -0.48 | -0.4 | -0.33 | n/a |
| Return on Capital (ROIC) | -0.5 | -0.69 | -0.18 | -0.69 | -0.7 | -0.69 | -0.52 | -0.43 | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 74.26% | 37.89% | 50.89% | -4.06K% | 19.45K% | n/a | 1.15K% | n/a | n/a |
| Net Profit Margin | -294.66% | -2.27K% | 34.90% | -41.64K% | 28.56K% | n/a | 1.18K% | n/a | n/a |
| Pretax Profit Margin | -299.98% | -2.40K% | 39.05% | -42.35K% | 33.70K% | n/a | 1.43K% | n/a | n/a |
| Operating Profit Margin | -284.16% | -2.89K% | -57.42% | -9.56K% | 32.39K% | n/a | 1.38K% | n/a | n/a |
| FCF Margin | -215.51% | -2.58K% | -15.83% | -7.22K% | 37.67K% | n/a | 1.05K% | n/a | n/a |
| EBITDA Margin | -260.56% | -2.79K% | -13.72% | -9.55K% | 30.79K% | n/a | 1.35K% | n/a | n/a |